About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The Role of Computed Tomography in the Phenotyping of COPD Patients

NCT05747235·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Aswan University

Age

18–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

All stable COPD patients that lastly confirmed to have the disease based on spirometry and past clinical history according to GOLD (2022).
Age above 18 years.

You may not be if

COPD patients associated with other chest diseases as collapse
COPD patients associated with consolidation
COPD patients unable to perform spirometry

The record

StatusCompleted

PhaseNo phase

Taking part50

StartedApr 2022

UpdatedFeb 2, 2024

Conditions

Where1

Islam Galal Sayed
Asyut, Egypt

Clareo Health | The Role of Computed Tomography in the Phenotyping of COPD Patients